(Q44118221)

30 November 2017

title

Clinical studies in asthmatics with a new non-extra fine HFA formulation of beclometasone dipropionate (BDP Modulite). (English)

1 reference

beclomethasone dipropionate

30 November 2017

0 references

1 reference

J Bousquet

1

1 reference

30 November 2017

L Cantini

series ordinal

2

1 reference

30 November 2017

publication date

1 August 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

96 Suppl D

1 reference

30 November 2017

page(s)

S17-27

1 reference

Beclomethasone dipropionate. A reappraisal of its pharmacodynamic properties and therapeutic efficacy after a decade of use in asthma and rhinitis

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2802%2980020-8

7 January 2021

Approaches and Challenges to Use Freon Propellant Replacements

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2802%2980020-8

7 January 2021

CFCs, their replacements, and the ozone layer.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2802%2980020-8

7 January 2021

Safety of propellants.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2802%2980020-8

7 January 2021

HFA-134a (1,1,1,2-tetrafluoroethane); lack of oncogenicity in rodents after inhalation.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2802%2980020-8

7 January 2021

An overview of the toxicology of HFA-134a (1,1,1,2-tetrafluoroethane).

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2802%2980020-8

7 January 2021

Twenty-eight-day double-blind safety study of an HFA-134a inhalation aerosol system in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2802%2980020-8

7 January 2021

Safety of hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2802%2980020-8

7 January 2021

Pharmacokinetics of chlorofluorocarbon and hydrofluoroalkane metered-dose inhaler formulations of beclomethasone dipropionate

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2802%2980020-8

7 January 2021

Improved targeting of beclomethasone diproprionate (250 micrograms metered dose inhaler) to the lungs of asthmatics with the Spacehaler

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2802%2980020-8

7 January 2021

Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2802%2980020-8

7 January 2021

A new HFA-134a propellant in the administration of inhaled BDP via the Jet spacer: controlled clinical trial vs the conventional CFC.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2802%2980020-8

7 January 2021

10.1016/S0954-6111(02)80020-8

Identifiers

DOI

1 reference

30 November 2017

1 reference